Brief: Immutep Announces Successful Completion Of FDA Project Optimus Requirements
13/10/2025 13:04
Oct 13 (Reuters) - Immutep Ltd IMM.AX: IMMUTEP ANNOUNCES SUCCESSFUL COMPLETION OF FDA PROJECT OPTIMUS REQUIREMENTS IMMUTEP LTD - 30MG DOSE AGREED FOR EFTILAGIMOD ALFA Source text: ID:nGNX5rswrR Further company coverage: IMM.AX (Reporting by Anhata Rooprai) ((Anhata.Rooprai@thomsonreuters.com;))